March 17 (Reuters) - Next Science Ltd (NXS) :
- DUE TO COVID19 OUTBREAK IN U.S., SEEING DISRUPTION TO ACTIVITIES INCLUDING REDUCED HOSPITAL VISITS BY DISTRIBUTION AGENTS
- SALES GROWTH HAS BEEN IMPACTED AND IS LIKELY TO CONTINUE
- TOO EARLY TO REASONABLY ANTICIPATE SALES IN Q2
- EXPECT COMMERCIAL LAUNCH OF 2 NEW PRODUCTS IN U.S. IN H2 2020
March 17 (Reuters) - Next Science Ltd (NXS) : DUE TO COVID19...
Add to My Watchlist
What is My Watchlist?